Advertisement

Topics

Eli Lilly Partners with German Biotech Against Autoimmune Disease

04:59 EDT 22 Aug 2017 | Labiotech.eu

Topas Therapeutics has signed a multi-year agreement with Eli Lilly to develop drug candidates for antigen-specific immunotherapy. The young Topas Therapeutics, a spin off from Evotec launched just last year, has managed to sign a research collaboration deal with big pharma Eli Lilly. ...

This awesome article Eli Lilly Partners with German Biotech Against Autoimmune Disease appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Original Article: Eli Lilly Partners with German Biotech Against Autoimmune Disease

NEXT ARTICLE

More From BioPortfolio on "Eli Lilly Partners with German Biotech Against Autoimmune Disease"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...